Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ATP in moderate to severe Alzheimer's disease (dose-finding, double-blind)
2013-004593-95Phase 2Completed
- Sponsor
- Ace Alzheimer Center Barcelona
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of magnesium adenosine triphosphate in Alzheimer's disease (AD), sponsored by Ace Alzheimer Center Barcelona. Primary endpoint: Brain metabolic changes by proton MRS. Started Feb 2014; status: completed.
02
Drugs
magnesium adenosine triphosphate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2013-004593-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004593-95.